Positron emission tomography in the management of lymphomas: a summary

被引:8
作者
O'Doherty, M. J. [1 ]
Hoskin, P. J. [2 ]
机构
[1] St Thomas Hosp, Guys & St Thomas NHS Trust, Clin PET Ctr, London SE1 7EH, England
[2] Mt Vernon Hosp, Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England
关键词
Positrons;
D O I
10.1007/s00259-003-1170-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S128 / S130
页数:3
相关论文
共 25 条
[1]   Whole-body positron emission tomography-CT: Optimized CT using oral and IV contrast materials [J].
Antoch, G ;
Freudenberg, LS ;
Stattaus, J ;
Jentzen, W ;
Mueller, SP ;
Debatin, JF ;
Bockisch, A .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 179 (06) :1555-1560
[2]  
Antoch G, 2002, J NUCL MED, V43, P1339
[3]  
BARRINGTON SF, 2003, EUR J NUCL MED MOL I
[4]   Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation [J].
Becherer, A ;
Mitterbauer, M ;
Jaeger, U ;
Kalhs, P ;
Greinix, HT ;
Karanikas, G ;
Pötzi, C ;
Raderer, M ;
Dudczak, R ;
Kletter, K .
LEUKEMIA, 2002, 16 (02) :260-267
[5]   PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients [J].
Burger, C ;
Goerres, G ;
Schoenes, S ;
Buck, A ;
Lonn, AHR ;
von Schulthess, GK .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (07) :922-927
[6]  
COFFEY J, 2003, EUR J NUCL MED MOL I
[7]  
ELSTROM R, 2003, BLOOD
[8]  
EVINSAPIR E, 2003, EUR J NUCL MED MOL I
[9]  
Haberkorn Uwe, 2001, Current Gene Therapy, V1, P163, DOI 10.2174/1566523013348760
[10]  
JACK AS, 2003, EUR J NUCL MED MOL I